OVERCOMING MULTIPLE MYELOMA DRUG RESISTANCE IN THE ERA OF CANCER “OMICS”

Multiple myeloma (MM) is amongst the most compelling examples of cancer in which research has markedly improved the length and quality of lives of those afflicted. Research efforts have led to 18 newly approved treatments over the last 12 years, including 7 in 2015. However, despite significant impr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Leuk Lymphoma
Auteurs principaux: Guang, Matthew Ho Zhi, McCann, Amanda, Bianchi, Giada, Zhang, Li, Dowling, Paul, Bazou, Despina, O’Gorman, Peter, Anderson, Kenneth C.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152877/
https://ncbi.nlm.nih.gov/pubmed/28610537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1337115
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires